The first DRIVE Webinar aims to help external stakeholders familiarize themselves with the project, its status and the main results of the first DRIVE Annual Forum.
The webinar is open for everybody interested in influenza vaccine studies.
On the Agenda: DRIVE Short Introduction, DRIVE governance, DRIVE first pilot season, DRIVE Communications, DRIVE coming season & new partners, How to get involved in DRIVE, and Questions and Answers.
Please register to the DRIVE webinar via https://attendee.gotowebinar.com/register/6458134772483224577
After registering, you will receive a confirmation email containing information on ways to join the webinar.
The DRIVE project (Development of Robust and Innovative Vaccine Effectiveness) started in July 2017 in the framework of the Innovative Medicines Initiative (IMI).
DRIVE aims to establish a European platform for studying brand-specific influenza vaccine effectiveness (IVE) and to develop a governance model for scientifically independent, robust and transparent IVE studies in a public-private partnership.
DRIVE organised its first Annual Forum in September 2018 in Istituto Superiore di Sanita, Rome to discuss with different stakeholders the DRIVE governance model, the lessons learnt from the pilot season 2017/18 and the best ways to communicate about Influenza Vaccine Effectiveness results. The Forum was attended by 34 stakeholder representatives, including ECDC and EMA.